drugset
drugset / Trial / NCT02000388

Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain

NCT02000388 ↗

Phase 4 Unknown 15 enrolled Citrus Valley Medical Research, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy, tolerability and safety of intranasal ketorolac tromethamine (SPRIX) as an option for pain management in post vasectomy patients.

Timeline

Start
2012-02
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Tromethamine Small molecule 31.5 mg Intranasal

Indications

No indication recorded.